AP
Armata Pharmaceuticals Inc
🇺🇸XNYS.ARMPUnited StatesHealthcare
$4.52USDdown -1.03 (-18.56%)OpenEnd of day6:09 PM
Price$4.52-1.03 (-18.56%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US04216R1023
- CUSIP
- 03211P103
Company
- Employees
- 61
- Headquarters
- Los Angeles, United States
- Website
- https://www.armatapharma.com
- CEO
- Dr. Deborah L. Birx M.D.
Market
- Shares outstanding
- 36.7M
- Market cap
- $165.93M
Highlights
- Market cap
- $165.93M
- EPS LTM
- -$7.74
- P/E LTM
- -1.29
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $5.2M+10.7%up year on year
- Net income
- -$282.61M-66,241.31%down year on year
- Gross margin
- 69.03%-2.12%down year on year
- Free cash flow
- -$24.47M+32.54%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.